Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο: https://hdl.handle.net/10442/19431
Export to:   BibTeX  | EndNote  | RIS
Εξειδίκευση τύπου : Άρθρο σε επιστημονικό περιοδικό
Τίτλος: Fabricating Polymer/Surfactant/Cyclodextrin Hybrid Particles for Possible Nose-to-Brain Delivery of Ropinirole Hydrochloride: In Vitro and Ex Vivo Evaluation
Δημιουργός/Συγγραφέας: Saitani, Elmina-Marina
Pippa, Natassa
Perinelli, Diego Romano
Forys, Aleksander
Papakyriakopoulou, Paraskevi
Lagopati, Nefeli
Bonacucina, Giulia
Trzebicka, Barbara
Gazouli, Maria
[EL] Πίσπας, Στέργιος[EN] Pispas, Stergiossemantics logo
Valsami, Georgia
Ημερομηνία: 2024-01-18
Γλώσσα: Αγγλικά
ISSN: 1422-0067
DOI: 10.3390/ijms25021162
Άλλο: 38256239
Περίληψη: Ropinirole is a non-ergolinic dopamine agonist used to manage Parkinson's disease and it is characterized by poor oral bioavailability. This study aimed to design and develop advanced drug delivery systems composed of poloxamer 407, a non-ionic surfactant (Tween 80), and cyclodextrins (methyl-β-CD or hydroxy-propyl-β-CD) for possible brain targeting of ropinirole after nasal administration for the treatment of Parkinson's disease. The hybrid systems were formed by the thin-film hydration method, followed by an extensive physicochemical and morphological characterization. The in vitro cytotoxicity of the systems on HEK293 cell lines was also tested. In vitro release and ex vivo mucosal permeation of ropinirole were assessed using Franz cells at 34 °C and with phosphate buffer solution at pH 5.6 in the donor compartment, simulating the conditions of the nasal cavity. The results indicated that the diffusion-controlled drug release exhibited a progressive increase throughout the experiment, while a proof-of-concept experiment on ex vivo permeation through rabbit nasal mucosa revealed a better performance of the prepared hybrid systems in comparison to ropinirole solution. The encouraging results in drug release and mucosal permeation indicate that these hybrid systems can serve as attractive platforms for effective and targeted nose-to-brain delivery of ropinirole with a possible application in Parkinson's disease. Further ex vivo and in vivo studies to support the results of the present work are ongoing.
Τίτλος πηγής δημοσίευσης: International journal of molecular sciences
Τόμος/Κεφάλαιο: 25
Τεύχος: 2
Θεματική Κατηγορία: [EL] Φαρμακευτική τεχνολογία[EN] Pharmaceutical technologysemantics logo
[EL] Νανοτεχνολογία[EN] Nanotechnologysemantics logo
[EL] Θεραπευτική. Φαρμακολογία[EN] Therapeutics.Pharmacologysemantics logo
[EL] Φυσική και θεωρητική χημεία[EN] Physical and theoretical chemistrysemantics logo
Λέξεις-Κλειδιά: Franz type diffusion cells
cryo-TEM images
cyclodextrins
ex vivo nasal permeability
nose-to-brain transport
poloxamer 407
ropinirole hydrochloride
surfactant
Κάτοχος πνευματικών δικαιωμάτων: © 2024 by the authors. Licensee MDPI, Basel, Switzerland.
Όροι και προϋποθέσεις δικαιωμάτων: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Ηλεκτρονική διεύθυνση στον εκδότη (link): https://doi.org/10.3390/ijms25021162
Εμφανίζεται στις συλλογές:Ινστιτούτο Θεωρητικής και Φυσικής Χημείας (ΙΘΦΧ) - Επιστημονικό έργο

Αρχεία σε αυτό το τεκμήριο:
Αρχείο Περιγραφή ΣελίδεςΜέγεθοςΜορφότυποςΈκδοσηΆδεια
Saitani et al_2024_ijms-25-01162.pdfopen access article3.68 MBAdobe PDFΔημοσιευμένη/του ΕκδότηccbyΔείτε/ανοίξτε